Atheline Pedersen-Major
Soborg, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
A multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice (PIONEER REAL Japan): Subgroup analyses.
Journal: Journal of diabetes investigation
Published: February 11, 2025
Real-world use of liraglutide for weight management according to label in the United Kingdom: A cohort study using the Clinical Practice Research Datalink primary care databases.
Journal: Diabetes, obesity & metabolism
Published: January 16, 2025
PIONEER REAL Japan: Primary results from a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice.
Journal: Journal of diabetes investigation
Published: April 12, 2024
Real-world safety profile of once-weekly semaglutide in people with type 2 diabetes: Analysis of pooled data from the SemaglUtide Real-world Evidence (SURE) programme.
Journal: Diabetes, obesity & metabolism
Published: February 01, 2024
PIONEER REAL Japan: Baseline characteristics of a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in clinical practice in Japan.
Journal: Journal of diabetes investigation
Published: December 13, 2023
Investigating the potential non-authorized use of two different formulations of liraglutide in Europe: A real-world drug utilization study.
Journal: Diabetes, obesity & metabolism
Published: September 09, 2022
Risk of Thyroid Cancer Associated with Use of Liraglutide and Other Antidiabetic Drugs in a US Commercially Insured Population.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: February 10, 2021
A joint industry-sponsored data monitoring committee model for observational, retrospective drug safety studies in the real-world setting.
Journal: Pharmacoepidemiology and drug safety
Published: May 11, 2020
Is there an association between liraglutide use and female breast cancer in a real-world setting?
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: December 13, 2018
Liraglutide use and evaluation of pancreatic outcomes in a US commercially insured population.
Journal: Diabetes, obesity & metabolism
Published: December 12, 2018
Performance of claims-based algorithms for identifying incident thyroid cancer in commercial health plan enrollees receiving antidiabetic drug therapies.
Journal: BMC health services research
Published: November 16, 2016
A prospective, claims-based assessment of the risk of pancreatitis and pancreatic cancer with liraglutide compared to other antidiabetic drugs.
Journal: Diabetes, obesity & metabolism
Published: July 24, 2013
Last Updated: 09/26/2026